NY-ESO-1-targeted T cell receptor therapy
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for NY-ESO-1-targeted T cell receptor therapy, covering 2016-05-18 to 2016-05-18. Get the full timeline:
Most recent: Clinical Trial Update: T Cell Receptor Immunotherapy Targeting NY-ESO-1 for Patients With NY-ESO-1 Expressing Melanoma [Phase 2]